Showing results (111-120 of 273) with videos related to

Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegenerationPeter Teismann, Kim Tieu, Dong-Kug Choi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2009
Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomesYilong Ma, Chengke Tang, Thomas Chaly, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2021
Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson DiseaseJasmin Galper, Manisha Balwani, Stanley Fahn, et al.
Journal of Neurology|March 15, 2003
Does personality change as a result of fetal tissue transplantation in the brain?Cynthia McRae, Eva Cherin, Gretchen Diem, et al.
Plos One|July 24, 2008
Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis miceRebecca Banerjee, R Lee Mosley, Ashley D Reynolds, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 23, 2003
Pathogenic role of glial cells in Parkinson's diseasePeter Teismann, Kim Tieu, Oren Cohen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2002
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson diseaseD C Wu, Vernice Jackson-Lewis, Miquel Vila, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2003
Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factorsErwan Bezard, Sandra Dovero, David Belin, et al.
Pageof 28